CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Iambic signs AbbVie deal, releases next generation of Enchant model

PartnershipPositive
AI Analysis

Summary

Iambic Therapeutics signed an R&D partnership with AbbVie and released the next generation of its Enchant AI model for drug discovery.

Outcome Details

R&D partnership agreement signed

Importance:6/10
Sentiment:
0.60
partnershipR&D collaborationAI/machine learningdrug discovery
Related Companies

Read the original article

Published by Endpoints News on September 21, 2026 2:45 PM

Read Original